End-use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

The hospitals and clinics segment led the intravenous equipment market with a 36.72% share in 2026. Its dominance is supported by the high volume of inpatient and outpatient procedures requiring intravenous therapy for medication delivery, fluid administration, blood transfusions, and nutritional support. These healthcare facilities also manage a broad spectrum of acute and chronic conditions, creating sustained demand for reliable intravenous equipment. Continuous investments in hospital infrastructure, patient safety initiatives, and advanced infusion practices further strengthen the segment’s leading position.

The ambulatory surgical centers segment is expected to witness the fastest growth during the forecast period as healthcare providers increasingly shift suitable surgical procedures toward cost-effective outpatient settings. Growing adoption of minimally invasive procedures, shorter patient recovery times, and rising demand for efficient perioperative care are encouraging wider use of intravenous equipment in these facilities. The expanding number of ambulatory surgical centers and their emphasis on streamlined clinical workflows are also contributing to accelerated segment growth.

Product Segment Analysis: IV Catheters (Largest Segment) vs Infusion Pumps (Fastest-Growing Segment)

In the intravenous equipment market, the IV catheters segment accounted for the largest share of 24.95% in 2026. IV catheters remain fundamental to intravenous therapy because they are used across virtually every healthcare setting for administering medications, fluids, blood products, and nutritional support. Their routine application in emergency care, surgical procedures, and long-term treatment, combined with continuous improvements in catheter design to enhance patient comfort and reduce complications, supports their widespread adoption.

The infusion pumps segment is projected to grow at the fastest pace during the forecast period due to increasing demand for accurate and programmable drug delivery systems. Rising use of complex infusion therapies, expanding adoption of smart pump technologies with safety features, and greater emphasis on minimizing medication errors are driving utilization across hospitals, specialty clinics, and home healthcare settings. The growing need for precise dose management in critical care and chronic disease treatment further supports the segment’s expansion.